𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C

✍ Scribed by Markus Mohler; Stefanie Seipp; Uli Tox; Wolfgang Stremmel; Lorenz Theilmann; Tobias Goeser

Publisher
Springer US
Year
1996
Tongue
English
Weight
156 KB
Volume
41
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quasispecies nature of hepatitis C virus
Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes
✍ Toyoda, Hidenori; Fukuda, Yoshihide; Nakano, Isao; Katano, Yoshiaki; Takayama, T πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

The quasispecies nature of hepatitis C virus (HCV) in patients with mixed HCV subtype infection was compared with that in patients with single HCV subtype infection. The number of HCV quasispecies was compared between 35 patients with mixed HCV subtype infection and 83 patients with single subtype i

Identification of novel HCV subgenome re
Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients
✍ Shintaro Yagi; Kenich Mori; Eiji Tanaka; Akihiro Matsumoto; Fumiko Sunaga; Kendo πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 894 KB

## Abstract In an effort to clarify the life cycle of HCV, the HCV genome in liver biopsies taken from chronic active hepatitis C patients undergoing interferon treatment was investigated. Molecular cloning by long distance reverse‐transcription polymerase chain reaction (RT‐PCR) revealed that the

Effects of ursodeoxycholic acid (UDCA) o
Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis
✍ E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 347 KB

The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u